HLA-DR/RFLP compatible corneal grafts.
Fifty-one elective high risk transplantations were matched according to HLA/DR antigens and RFLP-subtypes. The 18 months survival of the grafts are 93% in the matched group compared to 50% in a non-matched compatible historical control group.
Baggesen
K
K
Department of Ophthalmology, Arhus University Hospital, Denmark.
Ehlers
N
N
Lamm
L U
LU
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D016039:Corneal Transplantation / Q000276:immunology*; D004247:DNA / Q000032:analysis; D005260:Female; D006085:Graft Survival / Q000276:immunology*; D006684:HLA-DR Antigens / Q000235:genetics / Q000276:immunology*; D006650:Histocompatibility Testing; D006801:Humans; D008297:Male; D008875:Middle Aged; D012150:Polymorphism, Restriction Fragment Length; D011379:Prognosis
D006684:HLA-DR Antigens; D004247:DNA